CD276 and cancer: Matrix metalloproteinase inhibitors caused an increase of cell-surface CD276 expression in cancer cells and a decrease in soluble CD276 levels in the supernatant 13, indicating that soluble CD276 is produced by the cleavage of cell-surface CD276 via the effect of matrix metalloproteinase.